{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:46:33Z","timestamp":1788824793153,"version":"build-2803163510"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"vor","delay-in-days":571,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R21 CA242940"],"award-info":[{"award-number":["R21 CA242940"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 HL089778"],"award-info":[{"award-number":["R01 HL089778"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01-GM129781"],"award-info":[{"award-number":["R01-GM129781"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01-GM123056"],"award-info":[{"award-number":["R01-GM123056"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01GM140463"],"award-info":[{"award-number":["R01GM140463"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"NSF","doi-asserted-by":"publisher","award":["DMS-1712735"],"award-info":[{"award-number":["DMS-1712735"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"NSF","doi-asserted-by":"publisher","award":["DMS-2015259"],"award-info":[{"award-number":["DMS-2015259"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"NSF","doi-asserted-by":"publisher","award":["DMS-1811857"],"award-info":[{"award-number":["DMS-1811857"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"NSF","doi-asserted-by":"publisher","award":["DMS-2015373"],"award-info":[{"award-number":["DMS-2015373"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The ability to predict individualized treatment effects (ITEs) based on a given patient's profile is essential for personalized medicine. We propose a hypothesis testing approach to choosing between two potential treatments for a given individual in the framework of high-dimensional linear models. The methodological novelty lies in the construction of a debiased estimator of the ITE and establishment of its asymptotic normality uniformly for an arbitrary future high-dimensional observation, while the existing methods can only handle certain specific forms of observations. We introduce a testing procedure with the type I error controlled and establish its asymptotic power. The proposed method can be extended to making inference for general linear contrasts, including both the average treatment effect and outcome prediction. We introduce the optimality framework for hypothesis testing from both the minimaxity and adaptivity perspectives and establish the optimality of the proposed procedure. An extension to high-dimensional approximate linear models is also considered. The finite sample performance of the procedure is demonstrated in simulation studies and further illustrated through an analysis of electronic health records data from patients with rheumatoid arthritis.<\/jats:p>","DOI":"10.1111\/rssb.12426","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T07:07:56Z","timestamp":1627888076000},"page":"669-719","source":"Crossref","is-referenced-by-count":14,"title":["Optimal Statistical Inference for Individualized Treatment Effects in High-Dimensional Models"],"prefix":"10.1093","volume":"83","author":[{"given":"Tianxi","family":"Cai","sequence":"first","affiliation":[{"name":"Harvard University , Boston , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Tony Cai","sequence":"additional","affiliation":[{"name":"University of Pennsylvania , Philadelphia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Guo","sequence":"additional","affiliation":[{"name":"Rutgers University , Piscataway , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,8,2]]},"reference":[{"issue":"1","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1470-2045(09)70314-6","article-title":"Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptorpositive breast cancer on chemotherapy: a retrospective analysis of a randomised trial","volume":"11","author":"Albain","year":"2010","journal-title":"The Lancet Oncology"},{"issue":"4","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/rssb.12268","article-title":"Approximate residual balancing: debiased inference of average treatment effects in high dimensions","volume":"80","author":"Athey","year":"2018","journal-title":"Journal of the Royal Statistical Society: Series B (Statistical Methodology)"},{"key":"2023022501100906800_","volume-title":"Inference for high-dimensional sparse econometric models","author":"Belloni","year":"2011"},{"issue":"4","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/biomet\/asr043","article-title":"Square-root Lasso: pivotal recovery of sparse signals via conic programming","volume":"98","author":"Belloni","year":"2011","journal-title":"Biometrika"},{"issue":"6","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.3982\/ECTA9626","article-title":"Sparse models and methods for optimal instruments with an application to eminent domain","volume":"80","author":"Belloni","year":"2012","journal-title":"Econometrica"},{"issue":"2","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1257\/jep.28.2.29","article-title":"High-dimensional methods and inference on structural and treatment effects","volume":"28","author":"Belloni","year":"2014","journal-title":"Journal of Economic Perspectives"},{"issue":"4","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1214\/08-AOS620","article-title":"Simultaneous analysis of Lasso and Dantzig selector","volume":"37","author":"Bickel","year":"2009","journal-title":"Annals of Statistics"},{"issue":"19","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz","year":"2006","journal-title":"Journal of the American Medical Association"},{"issue":"1","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.21519","article-title":"The premier study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment","volume":"54","author":"Breedveld","year":"2006","journal-title":"Arthritis & Rheumatism: Official Journal of the American College of Rheumatology"},{"key":"2023022501100906800_","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-20192-9","volume-title":"Statistics for high-dimensional data: methods, theory and applications","author":"B\u00fchlmann","year":"2011"},{"issue":"2","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/02331888.2016.1265969","article-title":"Confidence intervals for high-dimensional linear regression: minimax rates and adaptivity","volume":"45","author":"Cai","year":"2017","journal-title":"Annals of Statistics"},{"issue":"4","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1214\/17-AOS1604","article-title":"Accuracy assessment for high-dimensional linear regression","volume":"46","author":"Cai","year":"2018","journal-title":"Annals of Statistics"},{"issue":"4","key":"2023022501100906800_","doi-asserted-by":"crossref","DOI":"10.1214\/17-AOS1604","article-title":"Supplement to \u201caccuracy assessment for high-dimensional linear regression\"","volume":"46","author":"Cai","year":"2018","journal-title":"Annals of Statistics"},{"issue":"2","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/rssb.12357","article-title":"Semi-supervised inference for explained variance in high-dimensional linear regression and its applications","volume":"82","author":"Cai","year":"2020","journal-title":"Journal of the Royal Statistical Society: Series B (Statistical Methodology)"},{"key":"2023022501100906800_","article-title":"Supplement to \u201coptimal statistical inference for individualized treatment effects in high-dimensional models\u201d","volume-title":"Journal of the Royal Statistical Society: Series B (Statistical Methodology)","author":"Cai","year":"2020"},{"issue":"5","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/acr.22865","article-title":"The 2015 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis should include new standards for Hepatitis B screening: comment on the article by Singh et al","volume":"68","author":"Calabrese","year":"2016","journal-title":"Arthritis Care & Research"},{"issue":"6","key":"2023022501100906800_","first-page":"2313","article-title":"The Dantzig selector: statistical estimation when p is much larger than n","volume":"35","author":"Cand\u00e8s","year":"2007","journal-title":"Annals of Statistics"},{"issue":"4","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1214\/17-AOS1594","article-title":"Efficient and adaptive linear regression in semi-supervised settings","volume":"46","author":"Chakrabortty","year":"2018","journal-title":"The Annals of Statistics"},{"issue":"9","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1158\/1078-0432.CCR-15-0426","article-title":"Precision medicine for advanced pancreas cancer: the individualized molecular pancreatic cancer therapy (impact) trial","volume":"21","author":"Chantrill","year":"2015","journal-title":"Clinical Cancer Research"},{"issue":"6","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/rheumatology\/kem041","article-title":"Combined tumour necrosis factor-alpha and tumour necrosis factor receptor genotypes could predict rheumatoid arthritis patients\u2019 response to anti-TNF-alpha therapy and explain controversies of studies based on a single polymorphism","volume":"46","author":"Chatzikyriakidou","year":"2007","journal-title":"Rheumatology (Oxford, England)"},{"issue":"1","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1137\/S003614450037906X","article-title":"Atomic decomposition by basis pursuit","volume":"43","author":"Chen","year":"2001","journal-title":"SIAM Review"},{"issue":"2","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"e000555","DOI":"10.1136\/rmdopen-2017-000555","article-title":"Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patients","volume":"3","author":"Danion","year":"2017","journal-title":"RMD Open"},{"issue":"25","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1200\/JCO.2005.02.857","article-title":"Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non\u2013small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib","volume":"23","author":"Eberhard","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"9636","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(08)61000-4","article-title":"Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET) a randomised, double-blind, parallel treatment trial","volume":"372","author":"Emery","year":"2008","journal-title":"The Lancet"},{"issue":"6990","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature02626","article-title":"Moving towards individualized medicine with pharmacogenomics","volume":"429","author":"Evans","year":"2004","journal-title":"Nature"},{"issue":"12","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/ng.2462","article-title":"High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis","volume":"44","author":"Eyre","year":"2012","journal-title":"Nature Genetics"},{"issue":"456","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1198\/016214501753382273","article-title":"Variable selection via nonconcave penalized likelihood and its oracle properties","volume":"96","author":"Fan","year":"2001","journal-title":"Journal of the American statistical Association"},{"issue":"1","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization paths for generalized linear models via coordinate descent","volume":"33","author":"Friedman","year":"2010","journal-title":"Journal of Statistical Software"},{"issue":"1","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/jpm6010011","article-title":"The biobank portal for partners personalized medicine: a query tool for working with consented biobank samples, genotypes, and phenotypes using i2b2","volume":"6","author":"Gainer","year":"2016","journal-title":"Journal of Personalized Medicine"},{"issue":"3","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1214\/14-AOS1221","article-title":"On asymptotically optimal confidence regions and tests for high-dimensional models","volume":"42","author":"van de Geer","year":"2014","journal-title":"Annals of Statistics"},{"issue":"4","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/art.21655","article-title":"Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial","volume":"54","author":"van der Heijde","year":"2006","journal-title":"Arthritis & Rheumatism"},{"issue":"1","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1214\/12-AOAS593","article-title":"Estimating treatment effect heterogeneity in randomized program evaluation","volume":"7","author":"Imai","year":"2013","journal-title":"The Annals of Applied Statistics"},{"key":"2023022501100906800_","volume-title":"A flexible framework for hypothesis testing in high-dimensions","author":"Javanmard","year":"2017"},{"issue":"3","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/rssb.12373","article-title":"A flexible framework for hypothesis testing in high dimensions","volume":"82","author":"Javanmard","year":"2020","journal-title":"Journal of the Royal Statistical Society: Series B (Statistical Methodology)"},{"issue":"1","key":"2023022501100906800_","first-page":"2869","article-title":"Confidence intervals and hypothesis testing for high-dimensional regression","volume":"15","author":"Javanmard","year":"2014","journal-title":"The Journal of Machine Learning Research"},{"issue":"2","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/amiajnl-2011-000492","article-title":"A translational engine at the national scale: informatics for integrating biology and the bedside","volume":"19","author":"Kohane","year":"2012","journal-title":"Journal of the American Medical Informatics Association"},{"issue":"10","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nrclinonc.2011.121","article-title":"Predictive biomarkers: a paradigm shift towards personalized cancer medicine","volume":"8","author":"La Thangue","year":"2011","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"1","key":"2023022501100906800_","first-page":"553","article-title":"The flare package for high dimensional linear regression and precision matrix estimation in R","volume":"16","author":"Li","year":"2015","journal-title":"Journal of Machine Learning Research"},{"issue":"8","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/acr.20184","article-title":"Electronic medical records for discovery research in rheumatoid arthritis","volume":"62","author":"Liao","year":"2010","journal-title":"Arthritis Care & Research"},{"issue":"9\u201310","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2119\/2008-00056.Liu","article-title":"Genome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in rheumatoid arthritis","volume":"14","author":"Liu","year":"2008","journal-title":"Molecular Medicine"},{"issue":"3","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.artmed.2007.07.003","article-title":"Ensemble methods for classification of patients for personalized medicine with high-dimensional data","volume":"41","author":"Moon","year":"2007","journal-title":"Artificial Intelligence in Medicine"},{"issue":"6","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1214\/13-AOS1170","article-title":"Confidence sets in sparse regression","volume":"41","author":"Nickl","year":"2013","journal-title":"Annals of Statistics"},{"issue":"6","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1586\/erm.12.59","article-title":"Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing","volume":"12","author":"Ong","year":"2012","journal-title":"Expert Review of Molecular Diagnostics"},{"issue":"6","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/ard.62.6.526","article-title":"Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis","volume":"62","author":"Padyukov","year":"2003","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"2","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1214\/10-AOS864","article-title":"Performance guarantees for individualized treatment rules","volume":"39","author":"Qian","year":"2011","journal-title":"Annals of Statistics"},{"issue":"1","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1186\/ar4439","article-title":"ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial","volume":"16","author":"Seegobin","year":"2014","journal-title":"Arthritis Research & Therapy"},{"issue":"19","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1200\/JCO.2006.08.2099","article-title":"Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non\u2013small-cell lung cancer","volume":"25","author":"Simon","year":"2007","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/sta4.78","article-title":"On sparse representation for optimal individualized treatment selection with penalized outcome weighted learning","volume":"4","author":"Song","year":"2015","journal-title":"Stat"},{"issue":"2","key":"2023022501100906800_","first-page":"269","article-title":"Scaled sparse linear regression","volume":"101","author":"Sun","year":"2012","journal-title":"Biometrika"},{"issue":"10","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nrrheum.2009.181","article-title":"Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis","volume":"5","author":"Taylor","year":"2009","journal-title":"Nature Reviews Rheumatology"},{"issue":"1","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","article-title":"Regression shrinkage and selection via the lasso","volume":"58","author":"Tibshirani","year":"1996","journal-title":"Journal of the Royal Statistical Society: Series B (Methodological)"},{"key":"2023022501100906800_","volume-title":"Debiasing linear prediction","author":"Tripuraneni","year":"2019"},{"key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1017\/CBO9780511794308.006","volume-title":"Compressed sensing: theory and applications","author":"Vershynin","year":"2012"},{"issue":"2","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1214\/09-AOS729","article-title":"Nearly unbiased variable selection under minimax concave penalty","volume":"38","author":"Zhang","year":"2010","journal-title":"Annals of Statistics"},{"issue":"1","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/rssb.12026","article-title":"Confidence intervals for low dimensional parameters in high dimensional linear models","volume":"76","author":"Zhang","year":"2014","journal-title":"Journal of the Royal Statistical Society: Series B (Statistical Methodology)"},{"issue":"499","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1080\/01621459.2012.695674","article-title":"Estimating individualized treatment rules using outcome weighted learning","volume":"107","author":"Zhao","year":"2012","journal-title":"Journal of the American Statistical Association"},{"issue":"517","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/01621459.2015.1093947","article-title":"Residual weighted learning for estimating individualized treatment rules","volume":"112","author":"Zhou","year":"2017","journal-title":"Journal of the American Statistical Association"},{"key":"2023022501100906800_","volume-title":"A projection pursuit framework for testing general high-dimensional hypothesis","author":"Zhu","year":"2017"},{"issue":"524","key":"2023022501100906800_","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1080\/01621459.2017.1356319","article-title":"Linear hypothesis testing in dense high-dimensional linear models","volume":"113","author":"Zhu","year":"2018","journal-title":"Journal of the American Statistical Association"}],"container-title":["Journal of the Royal Statistical Society Series B: Statistical Methodology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/rssb.12426","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/rssb.12426","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jrsssb\/article-pdf\/83\/4\/669\/49321647\/jrsssb_83_4_669.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jrsssb\/article-pdf\/83\/4\/669\/49321647\/jrsssb_83_4_669.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T16:16:06Z","timestamp":1725552966000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jrsssb\/article\/83\/4\/669\/7056102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,2]]},"references-count":59,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,8,2]]},"published-print":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.1111\/rssb.12426","relation":{},"ISSN":["1369-7412","1467-9868"],"issn-type":[{"value":"1369-7412","type":"print"},{"value":"1467-9868","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9]]},"published":{"date-parts":[[2021,8,2]]}}}